why choose us

Clinical Trials Search

Showing 6,390 of 132,085 result(s)
Fisetin to Improve Vascular Function in Older Adults

Status: Completed

Condition: Aging

Interventions: Fisetin dietary supplement

Date: 2023-11-10

MAAT For Young Adult Cancer Survivors

Status: NOT_YET_RECRUITING

Condition: Cancer

Interventions: MAAT is an evidence-based cognitive-behavioral therapy composed of eight 45-minute telehealth appointments and an accompanying workbook.

Date: 2023-11-10

Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

Status: Completed

Condition: Type 1 Diabetes

Interventions:

The Omnipod 5 System consists of a tubeless insulin Pod and the Omnipod® 5 App, installed on a designated Controller or compatible Android smartpho

Date: 2023-11-10

A Study to Compare the Relative Bioavailability of Brigatinib When Swallowed as a Solution Versus When Swallowed as a Tablet in Healthy Adults

Status: NOT_YET_RECRUITING

Condition: Healthy Volunteers

Interventions: Brigatinib oral solution

Date: 2023-11-10

Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus

Status: NOT_YET_RECRUITING

Condition: Type 1 Diabetes Mellitus

Interventions: BMF-219 is an orally bioavailable, covalent small-molecule menin inhibitor.

Date: 2023-11-10

Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults

Status: Completed

Condition: Pneumococcal Vaccines

Interventions: 0.5 ml dose of VAX-31 will be administered into the deltoid muscle at Day 1

Date: 2023-11-10

Evaluating Online Messages About Colon Cancer Screening

Status: Completed

Condition: Colonic Cancer

Interventions:

Participants will assess pairs of messages with the prompt, "Which of the messages below is more likely to make you want to get screened for c

Date: 2023-11-10

Cabozantinib With Ifosfamide in Ewing's Sarcoma and Osteosarcoma

Status: Completed

Condition: Ewing Sarcoma

Interventions: Participants will receive cabozantinib in combination with high-dose ifosfamide for 5 cycles.
If still on study therapy the participants will con

Date: 2023-11-10

Study of the Safety, Tolerability, and Pharmacokinetics of NUV001 Administered Orally to Healthy Adult Participants

Status: NOT_YET_RECRUITING

Condition: Healthy Volunteers

Interventions: 6 participants will be assigned to receive active treatment

Date: 2023-11-10